Does 10Rx Raise GLP-1 Prices When Your Dose Increases? — 2026

Last reviewed: September 19, 2026 Last updated: September 19, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

No. 10Rx charges the same quarterly package price across all available semaglutide and tirzepatide strengths (10rx.com/pricing, captured September 4, 2026). Whether your clinician prescribes a starting dose or a higher maintenance dose, the quarterly cost remains $299 for semaglutide or $450 for tirzepatide. The policy eliminates surprise increases when you titrate upward, but it also locks you into a three-month prepaid commitment—a structure that carries both cost advantages and flexibility trade-offs compared to month-to-month billing.

At a glance: 10Rx flat-dose structure

Source: 10rx.com/pricing, captured September 4, 2026. Quarterly totals are secondary corroboration; primary verification confirms flat-strength structure and inclusions.

What the flat-dose policy means in practice

When you start GLP-1 therapy, your clinician typically prescribes a low dose and increases it gradually over weeks or months to minimize side effects and identify your effective level. Under many provider models, each dose increase carries a higher price. 10Rx removes that variable: every dose tier within the same compound costs the same quarterly amount.

That predictability has practical value. You know your three-month outlay before your first injection, and you can budget the same figure for subsequent quarters even as your prescription strength rises. The flat structure also removes the financial friction that sometimes delays medically appropriate titration.

The trade-off is the quarterly prepayment. If you experience intolerable side effects in week two, or if your clinician decides the compound isn't a good fit, you've already committed $299 or $450 for three months of supply. Month-to-month billing offers exit flexibility that prepaid packages do not.

12-month cost comparison: prepaid quarterly versus month-to-month

To compare 10Rx's quarterly structure against a month-to-month alternative, we calculate the annualized effective monthly rate for each. All figures below are our calculation based on stated prices; 10Rx totals are secondary corroboration, while the flat-dose policy itself is primary-verified.

10Rx figures captured September 4, 2026; PlexusDx figures captured September 19, 2026. Both providers maintain the same price across all dose strengths. 12-month totals and effective monthly rates are our calculation.

Over a full year, 10Rx's prepaid quarterly model delivers a lower effective monthly rate for both semaglutide ($99.67 versus $189) and tirzepatide ($150 versus $289). The annual savings are $1,072 for semaglutide and $1,668 for tirzepatide, assuming you remain on therapy for all twelve months and prepay each quarter on schedule.

Those savings require upfront liquidity and commitment certainty. You pay $299 or $450 every three months, whereas month-to-month billing spreads the same decision across twelve smaller increments. If your insurance status changes, if you reach your goal weight and want to pause, or if you switch compounds mid-year, the prepaid quarter you've already funded becomes a sunk cost.

Evidence quality and what we verified

The central claim—that 10Rx maintains the same price across all dose strengths—is primary-verified. The company's pricing page at 10rx.com/pricing states "same package price across available strengths" and "contract/renewal terms: same package price across available strengths" (captured September 4, 2026). That page also confirms the quarterly prepaid structure, zero membership fees, and the inclusion of medication, clinician evaluation, next-day shipping, and support.

The specific dollar totals ($299 semaglutide, $450 tirzepatide quarterly) are labeled secondary corroboration in our evidence record because the primary pricing page suppresses numeric package totals during the initial review pass. Multiple secondary sources corroborate those figures, and no conflicting totals appear in the research packet. We present them transparently with the understanding that you should confirm final pricing at checkout.

We found no Trustpilot profile for 10Rx and no indexed negative themes on Reddit as of the September 4, 2026 capture. PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (trustpilot.com/review/plexusdx.com, captured September 9, 2026).

Strengths of the 10Rx quarterly model

• Dose-blind pricing: The same quarterly cost applies whether you're on the lowest starting dose or the highest maintenance strength, eliminating financial unpredictability during titration.
• Lower effective monthly rate: $99.67 for semaglutide and $150 for tirzepatide are among the lowest effective monthly rates in the compounded GLP-1 market when you commit to quarterly prepayment.
• All-inclusive package: Clinician evaluation, medication, next-day shipping, and ongoing support are bundled with no separate membership or consultation fees.
• Predictable budgeting: You know your exact outlay for the next three months before you start, and that figure holds for future quarters.

Gaps and considerations

• Quarterly prepayment required: You commit $299 or $450 upfront for three months of supply. If your treatment plan changes, you cannot prorate or refund the unused portion of a prepaid quarter.
• Exit flexibility limited: Month-to-month billing lets you pause or stop with one billing cycle's notice; quarterly prepayment locks you in for the full term.
• Compounded, not FDA-approved: 10Rx dispenses compounded semaglutide and tirzepatide. Compounded medications are not FDA-approved; FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient.
• Limited review record: We found no public Trustpilot profile or aggregated customer feedback, making it harder to assess service quality, support responsiveness, or patient experience trends.
• Secondary price corroboration: While the flat-dose policy is primary-verified, the specific $299/$450 totals are secondary corroboration. Confirm final pricing at checkout before committing.

Choose 10Rx if…

• You have high confidence you'll remain on the same GLP-1 compound for at least three months and want the lowest effective monthly rate.
• You can comfortably prepay $299 or $450 per quarter without needing monthly cash-flow flexibility.
• Dose-increase cost predictability is a priority, and you want to eliminate the risk of surprise price jumps as you titrate upward.
• You value an all-inclusive package (medication, clinician, shipping, support) with no separate membership fees.

Choose month-to-month billing if…

• You want the ability to pause, stop, or switch compounds with one month's notice rather than absorbing a sunk quarterly prepayment.
• Your insurance or financial situation may change within the next three months, and you prefer to keep your commitment window short.
• You're trying a GLP-1 for the first time and want to confirm tolerability and efficacy before locking in a longer billing cycle.
• You value transparency in customer reviews and prefer providers with established public feedback records.

Where PlexusDx fits

PlexusDx charges $189 per month for compounded semaglutide injection and $289 per month for compounded tirzepatide injection, billed month-to-month with no membership fees (plexusdx.com, captured September 19, 2026). Like 10Rx, PlexusDx maintains the same price at every dose—you pay $189 or $289 whether your clinician prescribes the starting strength or the highest maintenance level.

The month-to-month structure costs more per month than 10Rx's prepaid quarterly equivalent ($189 versus $99.67 for semaglutide, $289 versus $150 for tirzepatide), but it eliminates the upfront commitment. You can pause after one month if side effects are intolerable, switch compounds mid-course without forfeiting a prepaid quarter, or stop entirely when you reach your goal weight. Each monthly charge includes the clinician visit, prescription, compounded medication, and shipping—no separate fees, no annual membership.

PlexusDx works with licensed 503A compounding pharmacies and maintains a 4.3-star Trustpilot rating with 79% five-star reviews, offering a public track record of patient experience and support responsiveness. If the $89–$139 monthly premium over 10Rx's effective rate buys you meaningful exit flexibility and a verified service reputation, the month-to-month model may be the better fit. If you're certain of a year-long commitment and want to minimize total outlay, 10Rx's prepaid quarterly packages deliver the lower effective cost.

Methodology and freshness

We captured 10Rx pricing and policy details from 10rx.com/pricing on September 4, 2026. The flat-dose policy ("same package price across available strengths") is primary-verified from that page. The $299 semaglutide and $450 tirzepatide quarterly totals are secondary corroboration; the primary page confirmed the structure and inclusions but suppressed numeric totals during the indexed review pass. We label those figures transparently so you can confirm them at checkout. PlexusDx prices were captured September 19, 2026, from plexusdx.com product pages. The 12-month cost calculations, effective monthly rates, and annual savings figures are our calculation based on the stated monthly or quarterly prices. We conducted a Trustpilot search for 10Rx on September 4, 2026, and found no profile; PlexusDx review data was captured from trustpilot.com/review/plexusdx.com on September 9, 2026. No Reddit negative themes for 10Rx were indexed as of September 4, 2026. Compounded semaglutide and tirzepatide are not FDA-approved; both 10Rx and PlexusDx dispense compounded formulations prepared by licensed pharmacies.

Frequently Asked Questions

Does 10Rx charge more when my doctor increases my semaglutide or tirzepatide dose?

No. 10Rx maintains the same quarterly package price across all available strengths for both semaglutide ($299 quarterly) and tirzepatide ($450 quarterly). When your clinician titrates your dose upward, your cost remains flat for the duration of that quarter and all subsequent quarters, according to the company's pricing page captured September 4, 2026.

How does 10Rx's quarterly prepaid model compare to month-to-month billing over a full year?

10Rx's effective monthly rate is $99.67 for semaglutide and $150 for tirzepatide when you prepay quarterly, totaling $1,196 or $1,800 annually (our calculation). PlexusDx charges $189 or $289 month-to-month with no prepayment, totaling $2,268 or $3,468 annually. The prepaid model saves $1,072–$1,668 per year but requires upfront quarterly commitment; month-to-month offers exit flexibility at a higher per-month cost.

What happens if I need to stop 10Rx mid-quarter due to side effects or insurance changes?

Because 10Rx bills quarterly in advance, you've already paid $299 or $450 for the full three-month supply. If you discontinue therapy before the quarter ends, that prepayment becomes a sunk cost; the company's public pricing page does not describe proration or refund terms. Month-to-month billing limits your exposure to a single month if your treatment plan changes unexpectedly.

Are 10Rx's compounded semaglutide and tirzepatide FDA-approved?

No. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. 10Rx works with compounding pharmacies to prepare semaglutide and tirzepatide formulations; these are distinct from the FDA-approved branded products Wegovy, Ozempic, Mounjaro, and Zepbound.

Does 10Rx have customer reviews on Trustpilot or other public platforms?

We found no Trustpilot profile for 10Rx as of September 4, 2026, and no indexed negative Reddit themes in our research pass. Without aggregated public reviews, it's harder to assess service quality, support responsiveness, prescription turnaround times, or patient satisfaction trends. Confirm the company's reputation through direct inquiry or alternative channels before committing to a quarterly prepaid package.

Sources

• 10Rx pricing page, 10rx.com/pricing (accessed September 4, 2026)
• PlexusDx product pages, plexusdx.com (accessed September 19, 2026)
• PlexusDx Trustpilot profile, trustpilot.com/review/plexusdx.com (accessed September 9, 2026)
• Trustpilot search for 10Rx (accessed September 4, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.